These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 7859938)
21. Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. McCrimmon RJ; Evans ML; Fan X; McNay EC; Chan O; Ding Y; Zhu W; Gram DX; Sherwin RS Diabetes; 2005 Nov; 54(11):3169-74. PubMed ID: 16249441 [TBL] [Abstract][Full Text] [Related]
22. Noradrenergic and GABAergic systems in the medial hypothalamus are activated during hypoglycemia. Beverly JL; De Vries MG; Bouman SD; Arseneau LM Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R563-9. PubMed ID: 11208588 [TBL] [Abstract][Full Text] [Related]
24. Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus. Barnes MB; Lawson MA; Beverly JL Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1815-20. PubMed ID: 21957162 [TBL] [Abstract][Full Text] [Related]
25. In Vivo Photometry Reveals Insulin and 2-Deoxyglucose Maintain Prolonged Inhibition of VMH Vglut2 Neurons in Male Mice. Rawlinson S; Reichenbach A; Clarke RE; Nuñez-Iglesias J; Dempsey H; Lockie SH; Andrews ZB Endocrinology; 2022 Aug; 163(8):. PubMed ID: 35788848 [TBL] [Abstract][Full Text] [Related]
26. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Fioramonti X; Marsollier N; Song Z; Fakira KA; Patel RM; Brown S; Duparc T; Pica-Mendez A; Sanders NM; Knauf C; Valet P; McCrimmon RJ; Beuve A; Magnan C; Routh VH Diabetes; 2010 Feb; 59(2):519-28. PubMed ID: 19934009 [TBL] [Abstract][Full Text] [Related]
27. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. McCrimmon RJ; Fan X; Ding Y; Zhu W; Jacob RJ; Sherwin RS Diabetes; 2004 Aug; 53(8):1953-8. PubMed ID: 15277372 [TBL] [Abstract][Full Text] [Related]
28. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. McCrimmon RJ; Fan X; Cheng H; McNay E; Chan O; Shaw M; Ding Y; Zhu W; Sherwin RS Diabetes; 2006 Jun; 55(6):1755-60. PubMed ID: 16731839 [TBL] [Abstract][Full Text] [Related]
29. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Chan O; Cheng H; Herzog R; Czyzyk D; Zhu W; Wang A; McCrimmon RJ; Seashore MR; Sherwin RS Diabetes; 2008 May; 57(5):1363-70. PubMed ID: 18375441 [TBL] [Abstract][Full Text] [Related]
30. Lactate-induced release of GABA in the ventromedial hypothalamus contributes to counterregulatory failure in recurrent hypoglycemia and diabetes. Chan O; Paranjape SA; Horblitt A; Zhu W; Sherwin RS Diabetes; 2013 Dec; 62(12):4239-46. PubMed ID: 23939392 [TBL] [Abstract][Full Text] [Related]
31. Effect of antecedent hypoglycemia on cognitive function and on glycemic thresholds for counterregulatory hormone secretion in healthy humans. Mellman MJ; Davis MR; Brisman M; Shamoon H Diabetes Care; 1994 Mar; 17(3):183-8. PubMed ID: 8174445 [TBL] [Abstract][Full Text] [Related]
32. Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats. Farhat R; Su G; Sejling AS; Knight N; Fisher SJ; Chan O Diabetologia; 2019 Apr; 62(4):676-686. PubMed ID: 30627753 [TBL] [Abstract][Full Text] [Related]
33. Impaired Glutamatergic Neurotransmission in the Ventromedial Hypothalamus May Contribute to Defective Counterregulation in Recurrently Hypoglycemic Rats. Chowdhury GMI; Wang P; Ciardi A; Mamillapalli R; Johnson J; Zhu W; Eid T; Behar K; Chan O Diabetes; 2017 Jul; 66(7):1979-1989. PubMed ID: 28416628 [TBL] [Abstract][Full Text] [Related]
34. Effects of acetylcholine injection into the hypothalamus on the insulin and glucagon release. Ishikawa K; Suzuki M; Shimazu T Neuroendocrinology; 1982; 34(5):310-4. PubMed ID: 7043297 [TBL] [Abstract][Full Text] [Related]
35. Reduction in SGLT1 mRNA Expression in the Ventromedial Hypothalamus Improves the Counterregulatory Responses to Hypoglycemia in Recurrently Hypoglycemic and Diabetic Rats. Fan X; Chan O; Ding Y; Zhu W; Mastaitis J; Sherwin R Diabetes; 2015 Oct; 64(10):3564-72. PubMed ID: 26130763 [TBL] [Abstract][Full Text] [Related]
36. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Mitrakou A; Ryan C; Veneman T; Mokan M; Jenssen T; Kiss I; Durrant J; Cryer P; Gerich J Am J Physiol; 1991 Jan; 260(1 Pt 1):E67-74. PubMed ID: 1987794 [TBL] [Abstract][Full Text] [Related]
37. Brain insulin infusion does not augment the counterregulatory response to hypoglycemia or glucoprivation. Ishihara KK; Haywood SC; Daphna-Iken D; Puente EC; Fisher SJ Metabolism; 2009 Jun; 58(6):812-20. PubMed ID: 19375131 [TBL] [Abstract][Full Text] [Related]
38. Modulation by the hypothalamus of glucagon and insulin secretion in rabbits: studies with electrical and chemical stimulations. Shimazu T; Ishikawa K Endocrinology; 1981 Feb; 108(2):605-11. PubMed ID: 7004860 [TBL] [Abstract][Full Text] [Related]
39. Thioredoxin-1 Overexpression in the Ventromedial Nucleus of the Hypothalamus Preserves the Counterregulatory Response to Hypoglycemia During Type 1 Diabetes in Male Rats. Zhou C; Routh VH Diabetes; 2018 Jan; 67(1):120-130. PubMed ID: 29079703 [TBL] [Abstract][Full Text] [Related]
40. Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas. Hisatomi A; Maruyama H; Orci L; Vasko M; Unger RH J Clin Invest; 1985 Feb; 75(2):420-6. PubMed ID: 2857731 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]